Skip to content
Screener

Acadia Pharmaceuticals ACAD EBITDA

EBITDA at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$200.7M+543%
MapLight Therapeutics, Inc. logo
MapLight Therapeutics, Inc.MPLT
-$64.34M-175%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
-$43.19M-104%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$17.14M+125%
LBR
LB Pharmaceuticals IncLBRX
-$18.97M-263%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
-$60.59M-107%

Other financials

Income statement

See full
Revenue$308.0M+16.4%
Gross profit$279.6M+14.7%
Operating income$37.8M+16.9%
Net income$31.5M+18.1%
EPS (diluted)$0.18+12.5%

Balance sheet

See full
Cash & equivalents$385.0M+51.8%
Total debt$73.9M+31.2%
Total equity$1.3B+58.9%
Total assets$1.7B+42.2%

Cash flow

See full
Operating cash flow$100.8M+57.6%
CapEx$5.1M+1,613%
Free cash flow$95.7M+50.3%

Valuation

See full
Market cap$4.9B+23.1%
Enterprise value$4.59B+21.3%
P/E12.9×-5.0×
P/S4.3×+0.4×

Profitability

See full
Gross margin91.1%-0.8pp
Operating margin7.6%-15.7pp
Net margin33.4%+11.6pp
FCF margin18.9%—

Returns & leverage

See full
Return on equity35.7%+2.6pp
Debt / equity0.1×0.0×
Current ratio3.4×+0.5×

Where this comes from

Calculated from Acadia Pharmaceuticals’s reported figures.

$37.8Mebit+
$3.2MDepreciation Depletion & Amortization
=$40.99M

The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 4, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-333243

FAQ

What is Acadia Pharmaceuticals's EBITDA?
Acadia Pharmaceuticals (ACAD) reported EBITDA of $40.99M in Q2 2026.
How has Acadia Pharmaceuticals's EBITDA changed year-over-year?
Acadia Pharmaceuticals's EBITDA increased by 16.1% year-over-year, from $35.31M to $40.99M.
What is the long-term trend for Acadia Pharmaceuticals's EBITDA?
Over 3 years (2021 to 2025), Acadia Pharmaceuticals's EBITDA has grown at a -11.3% compound annual growth rate (CAGR), from -$167.03M to $116.57M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Ask your AI about Acadia Pharmaceuticals's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude